Springe direkt zu Inhalt

Dr. Sven Staufenbiel

Postdoktorand in der Arbeitsgruppe Prof. Dr. Roland Bodmeier (TP A01)
Pharmazeutische Technologie
Institut für Pharmazie
Freie Universität Berlin

sven.staufenbiel (at) fu-berlin.de

Teilprojekt A01:

Development of "smartNLC" and "ARTcrystals" for dermal application of drugs

SFB 1112- Publikationen:

  1. Colombo M, Staufenbiel S, Rühl E, Bodmeier R 2017. In situ determination of the saturation solubility of nanocrystals of poorly soluble drugs for dermal application. Int J Pharm 531:156-166 DOI 10.1016/j.ijpharm.2017.02.030
  2. Colombo M, Orthmann S, Bellini M, Staufenbiel S, Bodmeier R 2017. Influence of drug brittleness, nanomilling time, and freeze-drying on the crystallinity of poorly water-soluble drugs and its implications for solubility enhancement. Accepted for publication in: AAPS PharmSciTech DOI 10.1208/s12249-017-0722-4 (Epub ahead of print)
  3. Balzus B, Colombo M, Sahle FF, Zoubari G, Staufenbiel S, Bodmeier R 2016. Comparison of different in vitro release methods used to investigate nanocarriers intended for dermal application. Int J Pharm 513:247-254 DOI 10.1016/jijpharm.2016.09.33 (Epub ahead of print)
  4. Jager J, Obst K, Lohan SB, Voktorov J, Staufenbiel S, Renz H, Unbehauen M, Haag R, Hedtrich S, Teutloff C, Meinke MC, Danker K, Dommisch H 2017. Characterization of hyperbranched core-multishell nanocarriers as an innovative drug delivery system for the application at the oral mucosa. J Periodontal Res. Epub ahead of print. DOI 10.1111/jre.12487
  5. Zoubari G, Staufenbiel SVolz PAlexiev U, Bodmeier R 2017. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery. Eur J Pharm Biopharm 110:39-46 DOI 10.1016/j.ejpb.2016.10.021